This page contains a Flash digital edition of a book.
BIOTECHNOLOGY 61


Fig. 1. Electron microscopic image of B. megaterium (large cells) and E. coli (small cells). Photo courtesy of Prof. Dr. M. Rohde, TU Braunschweig, Germany.


Non-E. coli expression hosts represent a heyday for Gram- positive bacteria, says Arne Schulz.


Advances in bacterial hosts P


roteins are a group of organic molecules indispensable for life.


Tey are essential for the structure of all living organisms, and proteins also largely regulate the function of cells. Proteins include all enzymes and most hormones. Te main source of proteins is our daily food, deriving from plants and animals. Te human body breaks the proteins down to amino acids that then are used to form new proteins – in a process called protein synthesis. Dysregulation of this process is responsible for many diseases, for instance cancers and neurological disorders. Using bacteria as cellular factories and thus alternate sources of essential proteins is one of the major aims of gene expression.


A different aspect of artificial protein synthesis by means of bacteria is the production and supply of industrially relevant proteins. Bacillus subtilis is a major source of enzymes capable to degrade a variety of substrates. Popular examples are proteins


naturally secreted by Bacillus species into the growth medium, such as alkaline proteases as washing agent or amylases for the starch industry.


A major benefit of using bacteria as cellular factories for the production of proteins is that you can have them producing exactly the protein you want, and only a few steps are required from the genetically modified bacterium to the protein of interest in pure form.


Recent advances in preferred hosts Over the past decades, the intestinal Gram-negative bacterium Escherichia coli (commonly abbreviated to E. coli) has been the preferred host for artificial gene expression, mainly because it can be grown cost-effectively on widely available cheap substrates with high protein yields. However, its Gram-negative status, giving cause to problems related to the presence of endotoxins, renders it unable to efficiently secrete heterologous


proteins into the medium. Terefore, the availability of alternate hosts has become indispensable.


Tis gap could be filled by Gram- positive bacteria such as Bacillus megaterium, Bacillus subtilis and Lactococcus lactis. Tese bacterial hosts for gene expression and protein production are free of endotoxins, and efficiently working secretion pathways are present. In addition, Bacillus subtilis is classified by the FDA as GRAS (generally recognised as safe). A great variety of expression vectors for either bacterial host allows for the expression of a protein of interest.


Current state of play At present, about 60% of the commercially available enzymes are produced by Bacillus species, most notably Bacillus subtilis(1)


.


Vectors carrying signal peptides enable direct secretion of the protein into the growth medium, and different purification tags, for instance, His tag or Myc tag, facilitate easy purification(2) Work focusing on promoter


. www.scientistlive.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92